ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,602Medicare Part D Prescriptions Filled, Including Refills

Rank: 62 out of 198

$472K Total Retail Price of All Prescriptions

Rank: 69 out of 198

431 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
26% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 431 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

15% of this provider’s 431 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 8,452 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
LEVOTHYROXINE SODIUM 460 414 1 1
WARFARIN SODIUM 362 348 2 7
OMEPRAZOLE 330 303 3 3
AMLODIPINE BESYLATE 323 293 4 4
SIMVASTATIN 311 288 5 2
LISINOPRIL 308 282 6 6
FUROSEMIDE 255 250 7 5
HYDROCODONE-ACETAMINOPHEN 223 180 S3 8 8
TRAMADOL HCL 215 171 9 15
METOPROLOL SUCCINATE 186 174 10 11
GABAPENTIN 161 118 11 14
POTASSIUM CHLORIDE 152 146 12 9
METFORMIN HCL ER 150 122 13 64
SERTRALINE HCL 150 132 13 25
METOPROLOL TARTRATE 136 124 15 10
HYDROCHLOROTHIAZIDE 131 98 16 16
ATENOLOL 131 131 16 17
ATORVASTATIN CALCIUM 131 120 16 12
PRAVASTATIN SODIUM 130 95 19 19
CARVEDILOL 124 124 20 24
ALENDRONATE SODIUM 116 100 21 21
ZOLPIDEM TARTRATE 109 79 22 22
TAMSULOSIN HCL 107 90 23 27
METFORMIN HCL 103 76 24 13
CRESTOR 101 86 25 26
NAMENDA 89 89 26 33
LOSARTAN POTASSIUM 86 82 27 18
SPIRONOLACTONE 75 69 28 37
CITALOPRAM HBR 73 68 29 20
DIOVAN 65 64 30 34
PANTOPRAZOLE SODIUM 65 63 30 31
CLOPIDOGREL 59 51 32 42
PREDNISONE 55 53 33 29
FENTANYL 55 46 S2 33 73
BYSTOLIC 54 52 35 58
GLIMEPIRIDE 52 48 36 35
SYNTHROID 51 50 37 36
ESCITALOPRAM OXALATE 51 45 37 53
VESICARE 51 44 37 77
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 22, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.